The survivorship experience for patients with metastatic melanoma on immune checkpoint and BRAF-MEK inhibitors
2019 · Journal of Cancer Survivorship · 45 citations
https://doi.org/10.1007/s11764-019-00770-0
J
Julia Lai‐Kwon
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
72
Papers
829
Citations
17
h-index
27
i10-index
Julia Lai‐Kwon is an academic researcher from The University of Melbourne. The author has contributed to research in topics: Cancer survivorship and care & Cancer Immunotherapy and Biomarkers & Cutaneous Melanoma Detection and Management. The author has an h-index of 17, co-authored 62 publications.
ORCID: 0000-0002-5388-1695Papers by this author
worksImpact of immune checkpoint inhibitors and targeted therapy on health-related quality of life of people with stage III and IV melanoma: a mixed-methods systematic review
2023 · European Journal of Cancer · 18 citations
https://doi.org/10.1016/j.ejca.2023.02.005
Integrating Patient-Reported Outcomes Into the Care of People With Advanced Cancer—A Practical Guide
2024 · American Society of Clinical Oncology Educational Book · 13 citations
https://doi.org/10.1200/edbk_438512
Exploring the integration of patient-reported outcome measures in clinical practice: A cross-sectional survey of EORTC healthcare professionals
2025 · European Journal of Cancer · 4 citations
https://doi.org/10.1016/j.ejca.2025.115333
Qualitative evaluation of a multidisciplinary master of cancer sciences: impacts on graduates and influencing curricular factors
2024 · BMC Medical Education · 2 citations
https://doi.org/10.1186/s12909-024-05744-0
Patient-reported outcomes (PROs) as personalised cancer care: report from a 2023 Australian consensus meeting (PROActive)
2025 · EClinicalMedicine · 2 citations
https://doi.org/10.1016/j.eclinm.2025.103295
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat